When is oral prednisolone indicated for severe allergic rhinitis and what is the recommended dosing regimen?

Oral Prednisolone in Severe Allergic Rhinitis

Oral prednisolone should be reserved exclusively for very severe or intractable allergic rhinitis symptoms that have failed intranasal corticosteroids, and should be prescribed as a short 5-7 day course only. 1

When to Use Oral Prednisolone

Oral prednisolone is indicated in the following specific scenarios:

• Very severe nasal symptoms unresponsive to intranasal corticosteroids (INCS)
• Intractable rhinitis where standard therapies have failed
• Severe or incapacitating allergic conditions that are intractable to adequate trials of conventional treatment 2

Critical caveat: Intranasal corticosteroids must always be tried first before considering systemic corticosteroids 1. The evidence shows INCS are the most effective monotherapy for allergic rhinitis 1, and oral prednisolone offers no proven superiority over standard treatments in most cases 3.

Recommended Dosing Regimen

Duration: 5-7 days maximum 1

Dose: While guidelines specify short courses, the FDA label indicates prednisolone is approved for "control of severe or incapacitating allergic conditions" including seasonal or perennial allergic rhinitis 2. A typical adult dose would be 20-40 mg daily, though specific dosing should follow standard corticosteroid protocols.

Why This Restrictive Approach?

The evidence strongly discourages routine use of oral corticosteroids:

1. Single or recurrent intramuscular corticosteroids should be discouraged due to greater potential for long-term side effects 1

2. Recurrent administration of parenteral corticosteroids is contraindicated 1

3. Recent evidence shows no superiority: A 2025 randomized trial found prednisolone tablets (20 mg for 7 days) showed no statistically significant difference compared to antihistamine tablets in reducing symptoms or medication usage 3

4. Side effects include: insomnia, irritability, palpitations, hypertension, and potential for HPA axis suppression with prolonged use 1

Treatment Algorithm for Severe Allergic Rhinitis

First-line (moderate-to-severe disease):

• Intranasal corticosteroids monotherapy 4
• Onset within 12 hours, full benefit may take days to weeks 1

Second-line (inadequate response to INCS alone):

• Add intranasal antihistamine to INCS (for moderate-to-severe disease) 4
• This combination provides rapid relief (within minutes) plus sustained control 5

Third-line (very severe/intractable symptoms only):

• Short course oral prednisolone 5-7 days 1
• Reassess after completion and optimize topical therapy

Never use:

• Intramuscular depot corticosteroids 1, 6
• Long-term or repeated courses of oral corticosteroids for rhinitis

Common Pitfalls to Avoid

1. Prescribing oral steroids before optimizing INCS therapy - Ensure patients are using INCS correctly (directed away from septum, adequate duration of trial)

2. Using depot injections - These carry unacceptable systemic risks for a condition manageable with topical therapy 1, 6

3. Extending beyond 7 days - No evidence supports longer courses, and risks increase substantially

4. Not addressing adherence - Many patients fail INCS due to poor technique or inconsistent use, not true treatment failure

The 2017 Joint Task Force guidelines emphasize that INCS should routinely be prescribed as monotherapy for initial treatment over combination therapy with oral antihistamines 4. Only when symptoms remain very severe despite proper INCS use should oral prednisolone be considered, and then only briefly.